Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Lieberman

Showing results (941-950 of 1,142) with videos related to

Pageof 115
Sort By:
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|December 2, 2005
Neuroactive steroids are altered in schizophrenia and bipolar disorder: relevance to pathophysiology and therapeuticsChristine E Marx, Robert D Stevens, Lawrence J Shampine, et al.
Schizophrenia Research|August 18, 2009
Association study of the gamma-aminobutyric acid type a receptor gamma2 subunit gene with schizophreniaClement C Zai, Arun K Tiwari, Nicole King, et al.
The Pharmacogenomics Journal|April 27, 2023
Polygenic risk scores analyses of psychiatric and metabolic traits with antipsychotic-induced weight gain in schizophrenia: an exploratory studyKazunari Yoshida, Victoria S Marshe, Samar S M Elsheikh, et al.
Public Health Reports (Washington, D.C. : 1974)|November 30, 2025
Epidemiology of Leprosy (Hansen Disease) in Washington State, 2001-2023Julia C Bennett, Marcia J Goldoft, James W Lewis, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|May 15, 2010
No association of the serotonin transporter polymorphisms 5-HTTLPR and RS25531 with schizophrenia or neurocognitionThomas I Konneker, James J Crowley, Corey R Quackenbush, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|June 18, 1998
Serotonin subtype 2 receptor genes and clinical response to clozapine in schizophrenia patientsM Masellis, V Basile, H Y Meltzer, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|October 9, 2015
Association of orexin receptor polymorphisms with antipsychotic-induced weight gainArun K Tiwari, Eva J Brandl, Clement C Zai, et al.
Molecular Psychiatry|September 2, 2009
Genome-wide pharmacogenomic analysis of response to treatment with antipsychoticsJ L McClay, D E Adkins, K Aberg, et al.
Neuropsychobiology|May 23, 2017
Association Study of Serotonin 3 Receptor Subunit Gene Variants in Antipsychotic-Induced Weight GainClement C Zai, Arun K Tiwari, Nabilah I Chowdhury, et al.
Allergy|March 14, 2023
Immune response evolution in peanut epicutaneous immunotherapy for peanut-allergic childrenMarie Bastin, Warner W Carr, Carla M Davis, et al.
Pageof 115

Showing results (941-950 of 1,142) with videos related to

Sort By:
Pageof 115
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|December 2, 2005
Neuroactive steroids are altered in schizophrenia and bipolar disorder: relevance to pathophysiology and therapeuticsChristine E Marx, Robert D Stevens, Lawrence J Shampine, et al.
Schizophrenia Research|August 18, 2009
Association study of the gamma-aminobutyric acid type a receptor gamma2 subunit gene with schizophreniaClement C Zai, Arun K Tiwari, Nicole King, et al.
The Pharmacogenomics Journal|April 27, 2023
Polygenic risk scores analyses of psychiatric and metabolic traits with antipsychotic-induced weight gain in schizophrenia: an exploratory studyKazunari Yoshida, Victoria S Marshe, Samar S M Elsheikh, et al.
Public Health Reports (Washington, D.C. : 1974)|November 30, 2025
Epidemiology of Leprosy (Hansen Disease) in Washington State, 2001-2023Julia C Bennett, Marcia J Goldoft, James W Lewis, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|May 15, 2010
No association of the serotonin transporter polymorphisms 5-HTTLPR and RS25531 with schizophrenia or neurocognitionThomas I Konneker, James J Crowley, Corey R Quackenbush, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|June 18, 1998
Serotonin subtype 2 receptor genes and clinical response to clozapine in schizophrenia patientsM Masellis, V Basile, H Y Meltzer, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|October 9, 2015
Association of orexin receptor polymorphisms with antipsychotic-induced weight gainArun K Tiwari, Eva J Brandl, Clement C Zai, et al.
Molecular Psychiatry|September 2, 2009
Genome-wide pharmacogenomic analysis of response to treatment with antipsychoticsJ L McClay, D E Adkins, K Aberg, et al.
Neuropsychobiology|May 23, 2017
Association Study of Serotonin 3 Receptor Subunit Gene Variants in Antipsychotic-Induced Weight GainClement C Zai, Arun K Tiwari, Nabilah I Chowdhury, et al.
Allergy|March 14, 2023
Immune response evolution in peanut epicutaneous immunotherapy for peanut-allergic childrenMarie Bastin, Warner W Carr, Carla M Davis, et al.
Pageof 115